# clm_49C1DCF00977

subject: Amgen (/record/amgen.md)  
predicate: cash_and_equivalents  
value: 34,741,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2023-12-31  
published: 2023-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_71DDBB020158  
last_updated: 2026-11-08  
cite: AsOf. "Amgen cash and equivalents: 34,741,000,000 United States dollar", as of 2023-09-30 (until 2023-12-31). Claim clm_49C1DCF00977, https://asof.is/claim/clm_49C1DCF00977, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000064/0000318154-23-000064-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815423000064/0000318154-23-000064-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-10-31)

## Supersedes

- [Amgen](/record/amgen.md) | cash_and_equivalents | 34,248,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_49C1DCF00977](/claim/clm_49C1DCF00977.md) | [clm_ADA1FFC461F7](/claim/clm_ADA1FFC461F7.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.